Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
Masayuki Nitta, David Kozono, Richard Kennedy et al. · 2010
Read Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy by Masayuki Nitta, David Kozono, Richard Kennedy et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010767.txt.
Description
Masayuki Nitta and colleagues proposed an indirect attack on a deadly brain tumor, in PLOS ONE in 2010. Glioblastoma grows fast and resists most treatment. Many of these tumors lean on a growth receptor called EGFR. Drugs blocking EGFR have helped far less than hoped, so the team looked for a weakness the receptor itself creates.
EGFR-driven cells live with high oxidative stress, a rust-like strain inside the cell. Blocking a repair enzyme, PARP1, pushed that strain past what tumor cells could bear. Normal cells, under less stress, were spared. The tactic turns the tumor's own driving signal into its fatal flaw.
Catalog record
| CREATOR | Masayuki Nitta, David Kozono, Richard Kennedy et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010767